Cargando…
Study protocol for a randomised pragmatic trial comparing the clinical and cost effectiveness of lithium and quetiapine augmentation in treatment resistant depression (the LQD study)
BACKGROUND: Approximately 30–50% of patients with major depressive disorder can be classed as treatment resistant, widely defined as a failure to respond to two or more adequate trials of antidepressants in the current episode. Treatment resistant depression is associated with a poorer prognosis and...
Autores principales: | Marwood, L., Taylor, R., Goldsmith, K., Romeo, R., Holland, R., Pickles, A., Hutchinson, J., Dietch, D., Cipriani, A., Nair, R., Attenburrow, M.-J., Young, A. H., Geddes, J., McAllister-Williams, R. H., Cleare, A. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5485607/ https://www.ncbi.nlm.nih.gov/pubmed/28651526 http://dx.doi.org/10.1186/s12888-017-1393-0 |
Ejemplares similares
-
Patient perspectives of lithium and quetiapine augmentation treatment in treatment-resistant depression: A qualitative assessment
por: McKeown, Lucas, et al.
Publicado: (2022) -
A retrospective examination of care pathways in individuals with treatment-resistant depression
por: Day, Elana, et al.
Publicado: (2021) -
Oxford Lithium Trial (OxLith) of the early affective, cognitive, neural and biochemical effects of lithium carbonate in bipolar disorder: study protocol for a randomised controlled trial
por: Saunders, Kate E. A., et al.
Publicado: (2016) -
Search for supersymmetry with a dominant R-parity violating LQD coupling in $e^{+} e^{-}$ collisions at centre-of-mass energies of 130 GeV to 172 GeV
por: Barate, R, et al.
Publicado: (1999) -
Search for charginos and neutralinos in R-parity violating scenario with $\lambda 'LQD$ couplings at $\sqrt{s}$ = 189 GeV
por: Mulet-Marquis, C
Publicado: (1999)